Tag Archives: NASIADs
Celecoxib and Cardiovascular Disease
Written by Neil Kurtzman | 31st December 2016The New England Journal of Medicine has a paper in its current issue (Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis) that examines the safety of the COX-2 inhibitor celecoxib, best known under its brand name Celebrex, though now available in a generic formulation. This drug is the only COX-2 inhibitor available in the…
› Read the full entry
